SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Forest Laboratories, Inc. and TransTech Pharma, Inc. Enter Into License Agreement for the Development and Commercialization of Glucokinase Activators; Deal Valued at Up to $1.105 Billion